Prosecution Insights
Last updated: April 17, 2026
Application No. 15/731,719

Cortical loop fixation system for ligament and bone reconstruction

Non-Final OA §103§112
Filed
Jul 24, 2017
Examiner
WOZNICKI, JACQUELINE
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
unknown
OA Round
9 (Non-Final)
50%
Grant Probability
Moderate
9-10
OA Rounds
3y 9m
To Grant
76%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allow Rate
465 granted / 937 resolved
-20.4% vs TC avg
Strong +27% interview lift
Without
With
+26.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
107 currently pending
Career history
1044
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
46.2%
+6.2% vs TC avg
§102
19.0%
-21.0% vs TC avg
§112
31.3%
-8.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 937 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 09/11/25 has been entered. Response to Arguments Applicant's arguments filed 09/11/25 have been fully considered but they are not persuasive. On pages 10-11 regarding 112 rejections, Applicant argues support for “without tunneling the plurality of lengths of soft-tissue graft within the first bone” is found in page 7 lines 1-6 and 9-11, and Figure 1c, 2b, and 4a. The Examiner respectfully disagrees, noting none of these locations in the specification or figures references “without tunneling the plurality of lengths of soft-tissue graft within the first bone” as would be required to show support. The Examiner agrees page 7 lines 1-11 describes how drilling a tunnel has drawbacks. The specification is mute with regards to “tunneling” generally, and none of the figures of the instant invention discuss tunneling one way or another. The specification is also mute with regards to a plurality of lengths being tunneled through the bone. On pages 12-17 Applicant argues the amendment overcomes the rejection of record. The Examiner respectfully refers to the rejection below regarding amended claims. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 7, 12-14, 17-20, 23, 26-30 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claims 1, 13, and 28 are rejected for having new matter for claiming a “plurality of lengths of the soft-tissue graft” “extend from the first bone to a second bone…without tunneling the plurality of lengths of soft-tissue graft within the first bone”. Notably, the disclosure does not discuss how the “plurality of lengths” of the graft relate to the first bone at all. While the specification page 7 lines 1-9 appears to state negative outcomes from placing “a biologic soft-tissue graft” within “tunnels 22, 23 to replace the spanning ligament 1”, this does not appear to relate to the plurality of lengths in any way. It also only appears to relate to drilling in the bone, and does not refer to tunneling. Claim 29 is rejected for having new matter, for claiming “ arranging the plurality of lengths of the soft-tissue graft to extend from the first bone to the second bone…without tunneling the plurality of lengths…within the second bone”. Notably, there is no support for this in the originally filed disclosure, since it does not discuss whether or not the soft tissue graft can/should extend within the second bone at all, or whether/how the “plurality of lengths” could extend relating to either the first or second bone. The Examiner refers Applicant to MPEP 2173.05(i) which states that “[t]he mere absence of a positive recitation is not basis for an exclusion. Any claim containing a negative limitation which does not have basis in the original disclosure should be rejected under 35 U.S.C. 112, first paragraph, as failing to comply with the written description requirement.” Remaining claims are rejected for depending on a claim with new matter. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 1, 7, 13, 17-19, 28-30 is/are rejected under 35 U.S.C. 103 as being unpatentable over Jurgutis (US 4592346 A) in view of Hlavacek et al. (US 4792336 A) hereinafter known as Hlavacek, and further in view of Wevers (US 4246660 A). Regarding claims 1 and 13 Jurgutis discloses a method of intra-articular ligament reconstruction (Column 1 lines 6-8, 11-13; Figure 1 shows an anterior cruciate ligament (ACL) reconstruction) comprising: fixing/capturing a soft-tissue graft (Column 2 lines 36-38) on a native cortical bone surface of a native first bone of a joint within a human body (see Figure 1 where ligament 11 is fixed on the top outer surface of bone 10) between a first two sites of the first bone (Figures 1-2 show the graft 11 fixed between sites corresponding to legs 24/21/20/25; two of the legs and their corresponding locations where they dig into the bone 10 are considered to be the first two sites) with a first loop extending over the bone surface and engaging the first two sites (Figures 1-2 shows the top surface 15 of the loop extending over the surface of the bone to join the two sites represented at the legs 24/21/20/25); arranging a length of the graft to extend from the first bone to a second bone of the joint (Figure 1 shows the ligament 11 extending between the two bones of the knee joint) to restore an anatomy of a native intra-articular ligament with the soft-tissue graft (Figure 1; Column 1 lines 6-11); and fixing/connecting the graft to the second bone (Figure 1; Column 2 lines 42-44), but is silent with regards to the graft having a plurality of lengths, and the method including fixing the graft at a native intra-articular ligament attachment site of the first bone and the second bone, and extending the soft-tissue graft without tunneling within the first bone. However, regarding claims 1 and 13 Wevers teaches that methods of ligament reconstruction can include fixing a graft at a native ligament attachment site (Column 5 lines 19-22) so the graft extends without tunneling a first bone (Figure 4). Jurgutis and Wevers are involved in the same field of endeavor, namely ligament reconstruction methods. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of Jurgutis by securing the tendon in place without tunneling at a native site as is taught by Wevers since the courts have held that choosing from a finite number of identified, predictable solutions with a reasonable expectation of success results in a prima facie case of obviousness. See MPEP 2143 (I)(E). In this case, the securement of the ligaments without tunneling, to native attachment sites would have been obvious to try in order to mimic native anatomy. Considering the Combination is repair an ACL, the person of ordinary skill in the art understands the obviousness of securing the ligament of the Combination at the native intra-articular ACL attachment sites of the two bones. Further, regarding claims 1 and 13 Hlavacek teaches that ligament reconstruction with a soft-tissue graft (Column 1 lines 11-13) can include a plurality of lengths of graft (Figures 1-2, Column 4 lines 58-59). Jurgutis and Hlavacek are involved in the same field of endeavor, namely soft-tissue grafts. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of the Jurgutis Wevers Combination so that the graft included multiple lengths as is taught by Hlavacek since the courts have held that the simple substitution of one known element for another to obtain predictable results in a prima facie case of obviousness. See MPEP 2143 (I)(B). In this case, the use of a graft made of multiple fibers (or lengths) of material is considered obvious to try and substitute for the ligament 11 of Jurgutis. Regarding claim 7 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, wherein Jurgutis further discloses the graft is unfolded (Figure 1 shows an unfolded ligament 11), and wherein Hlavacek further teaches their graft is unfolded (Figures 2 and 4; Column 4 lines 59-61 parallel fibers). Regarding claims 17-18 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, wherein Hlavacek further teaches at least two of the plurality of lengths of soft-tissue graft are discontinuous from each other (Figures 2, 4;Column 4 lines 58-59). Regarding claim 19 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, wherein Jurgutis further discloses fixing the graft to the second bone includes the graft being fixed on a native cortical bone surface of the second bone between a second two sites of the second bone with a second loop extending over the surface and engaging the second two sites (Figure 1; Column 2 lines 42-44; the ligament 11 extends to the second bone of the knee joint with staple 13 including four attachment sites at four respective legs (Fig 2 items 20/21/24/25), two of which are considered to be the second two sites, with the loop being represented by the legs and surface 15 of the staple 12). Regarding claim 29 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, wherein Wevers further teaches the graft can extend from the first to the second bone without tunneling within the second bone (Figure 4). Regarding claim 30 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, wherein Jurgutis further teaches the ligament being reconstructed is an intra-articular ligament (Figure 1 – as is best understood this ligament is intra-articular), and wherein Hlaveck further teaches the ligament is intra-articular (Column 1 lines 13-14). Regarding claim 28 Jurgutis discloses a method of intra-articular ligament reconstruction (Column 1 lines 6-8, 11-13; Figure 1 shows an anterior cruciate ligament (ACL) reconstruction) comprising: fixing a soft-tissue graft (Column 2 lines 36-38; Figure 1 item 11) on a first location of a native cortical bone surface of a native first bone of a joint within a human body, and fixing the graft on a second location of the surface so the graft is captured on the surface between the first and second locations (Figure 1 shows the graft 11 fixed at four locations with legs 20/21/24/25 of the connector 12 representing each fixation point); arranging a length of the graft to extend from the first bone to a second bone of the joint (Figure 1 shows the ligament 11 extending between the two bones of the knee joint) to restore an anatomy of a native intra-articular ligament with the soft-tissue graft (Figure 1; Column 1 lines 6-11); and fixing the graft to the second bone (Figure 1; Column 2 lines 42-44), but is silent with regards to the graft having a plurality of lengths, and the method including fixing the graft at a native intra-articular ligament attachment site, and extending the soft-tissue graft without tunneling within the first bone. However, regarding claims 28 Wevers teaches that methods of ligament reconstruction can include fixing a graft at a native ligament attachment site (Column 5 lines 19-22) so the graft extends without tunneling a first bone (Figure 4). Jurgutis and Wevers are involved in the same field of endeavor, namely ligament reconstruction methods. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of Jurgutis by securing the tendon in place without tunneling at a native site as is taught by Wevers since the courts have held that choosing from a finite number of identified, predictable solutions with a reasonable expectation of success results in a prima facie case of obviousness. See MPEP 2143 (I)(E). In this case, the securement of the ligaments without tunneling, to native attachment sites would have been obvious to try in order to mimic native anatomy. Considering the Combination is repair an ACL, the person of ordinary skill in the art understands the obviousness of securing the ligament of the Combination at the native intra-articular ACL attachment sites of the two bones. However, regarding claim 28 Hlavacek teaches that ligament reconstruction with a soft-tissue graft (Column 1 lines 11-13) can include a plurality of lengths of graft (Figures 1-2, Column 4 lines 58-59). Jurgutis and Hlavacek are involved in the same field of endeavor, namely soft-tissue grafts. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of the Jurgutis Wevers Combination so that the graft included multiple lengths as is taught by Hlavacek since the courts have held that the simple substitution of one known element for another to obtain predictable results in a prima facie case of obviousness. See MPEP 2143 (I)(B). In this case, the use of a graft made of multiple fibers (or lengths) of material is considered obvious to try and substitute for the ligament 11 of Jurgutis. Claims 12, 14, 20, 23, 26 is/are rejected under 35 U.S.C. 103 as being unpatentable over Jurgutis, Wevers, and Hlavacek as is applied above, further in view of Frazier (US 5968045 A). Regarding claims 12, 23, and 26 the Jurgutis Wevers Hlavacek Combination teaches the method of ligament reconstruction of claim 13 substantially as is claimed, but is silent with regards to the graft being captured on the surface with a second loop so the graft is on the bone surface between the two loops. However, regarding claims 12, 23, and 26, Frazier teaches a method of ligament reconstruction that includes capturing a soft-tissue graft (Figure 3 item 1) on a bone surface (Figure 3 item 31) in two locations on the bone surface (Figure 3 shows two staples 37 securing the graft on two locations on one bone surface), so that the graft is fixed on the surface between the second two sites of the first bone (clm 12) (Figure 3). Jurgutis and Frazier are involved in the same field of endeavor, namely soft-tissue repair. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of the Jurgutis Wevers Hlavacek Combination so that the graft is captured at two locations as is taught by Frazier so that the Combination captures the graft with a second loop, since the courts have held that choosing from a finite number of identified, predictable solutions with a reasonable expectation of success results in a prima facie case of obviousness. See MPEP 2143 (I)(E). In this case, the use of any known pattern of securement, including that shown by Frazier, would have been obvious to try. The Examiner notes that the Combination results in the use of two staples, which each fix the graft on the bone surface, and each engaging in (at least) two sites (claim 12). Regarding claim 14 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 13 substantially as is claimed, but is silent with regards to capturing the graft on the bone surface with a second loop so the graft is on the surface between the two loops. However, regarding claim 14 Frazier teaches a method of ligament reconstruction that includes capturing a soft-tissue graft (Figure 3 item 1) on a bone surface (Figure 3 item 31) in two locations on the bone surface so the graft extends over the surface between the two locations (Figure 3 shows the two locations of securement at staples 37 with the graft extending therebetween). Jurgutis and Frazier are involved in the same field of endeavor, namely soft-tissue repair. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of the Jurgutis Wevers Hlavacek Combination so that the graft is captured at two locations as is taught by Frazier so that the Combination captures the graft with a second loop, since the courts have held that choosing from a finite number of identified, predictable solutions with a reasonable expectation of success results in a prima facie case of obviousness. See MPEP 2143 (I)(E). In this case, the use of any known pattern of securement, including that shown by Frazier, would have been obvious to try. Regarding claim 20 the Jurgutis Wevers Hlavacek Frazier Combination teaches the method of claim 14 substantially as is claimed, wherein Jurgutis further discloses the graft is captured on a cortical bone surface of the second bone between a third two sites of the second bone, with a third loop extending over the surface of the second bone and engaging the third two sites (Figure 1; Column 2 lines 42-44; the ligament 11 extends to the second bone of the knee joint with staple 13 including four attachment sites at four respective legs (Fig 2 items 20/21/24/25)). Claim 27 is/are rejected under 35 U.S.C. 103 as being unpatentable over Jurgutis, Wevers, and Hlavacek as is applied above, further in view of Del Medico (US 4913144 A). Regarding claim 27 the Jurgutis Wevers Hlavacek Combination teaches the method of claim 1 substantially as is claimed, but is silent with regards to the loop having an adjustable length. However, regarding claim 27 Del Medico teaches a bone fastener (Abstract) which secures at (at least) two sites (represented by legs Figure 1 items 12, 14)) and includes an adjustable length (Abstract). Jurgutis and Del Medico are involved in the same field of endeavor, namely bone fasteners. It would have been obvious to one of ordinary skill in the art at the time the invention was filed to modify the method of the Jurgutis Wevers Hlavacek Combination so that the loop has an adjustable length as is taught by Del Medico in order to ensure the loop can be fit to whatever size, diameter, or bulk of ligament is desired, thus ensuring greater compatibility with fibers of different make/models and increasing the number of patients the method can help. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jacqueline Woznicki whose telephone number is (571)270-5603. The examiner can normally be reached M-Th 10am-6pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached on 408-918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Jacqueline Woznicki/Primary Examiner, Art Unit 3774 10/27/25
Read full office action

Prosecution Timeline

Jul 24, 2017
Application Filed
Feb 19, 2019
Non-Final Rejection — §103, §112
Apr 29, 2019
Response Filed
Aug 16, 2019
Final Rejection — §103, §112
Oct 10, 2019
Notice of Allowance
Dec 03, 2019
Response after Non-Final Action
Dec 29, 2019
Response after Non-Final Action
Mar 30, 2020
Response after Non-Final Action
May 18, 2020
Response after Non-Final Action
May 22, 2020
Response after Non-Final Action
May 26, 2020
Response after Non-Final Action
May 26, 2020
Response after Non-Final Action
Feb 19, 2021
Response after Non-Final Action
May 13, 2021
Non-Final Rejection — §103, §112
Oct 20, 2021
Interview Requested
Oct 29, 2021
Applicant Interview (Telephonic)
Oct 29, 2021
Response Filed
Nov 06, 2021
Examiner Interview Summary
Feb 18, 2022
Final Rejection — §103, §112
May 31, 2022
Interview Requested
Jun 03, 2022
Applicant Interview (Telephonic)
Jun 18, 2022
Examiner Interview Summary
Jul 01, 2022
Request for Continued Examination
Jul 12, 2022
Response after Non-Final Action
Dec 11, 2022
Non-Final Rejection — §103, §112
Jun 09, 2023
Interview Requested
Jun 19, 2023
Response Filed
Nov 18, 2023
Final Rejection — §103, §112
Mar 06, 2024
Notice of Allowance
Apr 30, 2024
Response after Non-Final Action
Jun 05, 2024
Response after Non-Final Action
Jun 05, 2024
Response after Non-Final Action
Jun 18, 2024
Response after Non-Final Action
Jun 24, 2024
Response after Non-Final Action
Jun 24, 2024
Response after Non-Final Action
Jul 01, 2024
Response after Non-Final Action
Nov 06, 2024
Non-Final Rejection — §103, §112
Mar 07, 2025
Interview Requested
Mar 18, 2025
Applicant Interview (Telephonic)
Mar 18, 2025
Examiner Interview Summary
Mar 19, 2025
Response Filed
Apr 07, 2025
Final Rejection — §103, §112
Sep 11, 2025
Request for Continued Examination
Oct 01, 2025
Response after Non-Final Action
Feb 23, 2026
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12588992
EASY-TO-CONTROL INTERVENTIONAL INSTRUMENT DELIVERY DEVICE
2y 5m to grant Granted Mar 31, 2026
Patent 12582526
MEDICAL IMPLANT DEVICE
2y 5m to grant Granted Mar 24, 2026
Patent 12569336
CATHETER SYSTEM FOR IMPLANTATION OF PROSTHETIC HEART VALVES
2y 5m to grant Granted Mar 10, 2026
Patent 12521226
SURGICAL FIXATION SYSTEMS AND ASSOCIATED METHODS FOR PERFORMING TISSUE REPAIRS
2y 5m to grant Granted Jan 13, 2026
Patent 12508136
TRANSFEMORAL PROSTHESIS FOR WALKING, SITTING-STANDING, STAIR CLIMBING
2y 5m to grant Granted Dec 30, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

9-10
Expected OA Rounds
50%
Grant Probability
76%
With Interview (+26.6%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 937 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month